Charlton M et al. |
Everolimus Is Associated With Less Weight Gain Than Tacrolimus 2 Years After Liver Transplantation: Results of a Randomized Multicenter Study. |
2017 |
Transplantation |
pmid:28817434
|
Cvetkovic M et al. |
The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK506 on bone mineral metabolism in vivo. |
1994 |
Transplantation |
pmid:7513912
|
Singh N et al. |
Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. |
2000 |
Transplantation |
pmid:10708096
|
Zoppo A et al. |
Trimetazidine counteracts tacrolimus nephrotoxicity in a hypertensive liver transplant patient. |
1999 |
Transplantation |
pmid:10551656
|
Tzakis AG et al. |
Preliminary experience with campath 1H (C1H) in intestinal and liver transplantation. |
2003 |
Transplantation |
pmid:12717207
|
Khanna A et al. |
Donor bone marrow potentiates the effect of tacrolimus on nonvascularized heart allograft survival: association with microchimerism and growth of donor dendritic cell progenitors from recipient bone marrow. |
1998 |
Transplantation |
pmid:9500620
|
Manez R et al. |
Rejection and hepatitis in liver transplants. |
1994 |
Transplantation |
pmid:7517080
|
Cao W et al. |
Effects of rapamycin on growth factor-stimulated vascular smooth muscle cell DNA synthesis. Inhibition of basic fibroblast growth factor and platelet-derived growth factor action and antagonism of rapamycin by FK506. |
1995 |
Transplantation |
pmid:7532879
|
Timmermann W et al. |
Videomicroscopic imaging of graft mucosa for monitoring immunosuppressive therapy after small intestinal transplantation in rats. |
1999 |
Transplantation |
pmid:10401762
|
Fabrega AJ et al. |
Enhancement of allograft survival by single intraoperative donor-specific blood transfusion combined with FK506. |
1993 |
Transplantation |
pmid:7506458
|
Jain A et al. |
FK506 and pregnancy in liver transplant patients. |
1993 |
Transplantation |
pmid:7506459
|
Naesens M et al. |
Multidrug resistance protein 2 genetic polymorphisms influence mycophenolic acid exposure in renal allograft recipients. |
2006 |
Transplantation |
pmid:17060857
|
Dominguez J et al. |
Conversion to rapamycin immunosuppression in renal transplant recipients: report of an initial experience. |
2000 |
Transplantation |
pmid:11063349
|
Conrotto D et al. |
Dramatic increase of tacrolimus plasma concentration during topical treatment for oral graft-versus-host disease. |
2006 |
Transplantation |
pmid:17060865
|
Khanna A et al. |
Tacrolimus induces increased expression of transforming growth factor-beta1 in mammalian lymphoid as well as nonlymphoid cells. |
1999 |
Transplantation |
pmid:10071036
|
Jiang H et al. |
Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production. |
2002 |
Transplantation |
pmid:12085006
|
Stojanovic J et al. |
Immune Desensitization Allows Pediatric Blood Group Incompatible Kidney Transplantation. |
2017 |
Transplantation |
pmid:27463537
|
Bechstein WO et al. |
Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: 1-year results of a large multicenter trial. |
2004 |
Transplantation |
pmid:15114089
|
Lo A et al. |
Comparison of sirolimus-based calcineurin inhibitor-sparing and calcineurin inhibitor-free regimens in cadaveric renal transplantation. |
2004 |
Transplantation |
pmid:15114090
|
Shoker A et al. |
Heightened CD40 ligand gene expression in peripheral CD4+ T cells from patients with kidney allograft rejection. |
2000 |
Transplantation |
pmid:10949194
|
Levitsky J et al. |
Allospecific regulatory effects of sirolimus and tacrolimus in the human mixed lymphocyte reaction. |
2011 |
Transplantation |
pmid:21239962
|
Shackleton CR et al. |
Lack of correlation between the magnitude of preservation injury and the incidence of acute rejection, need for OKT3, and conversion to FK506 in cyclosporine-treated primary liver allograft recipients. |
1995 |
Transplantation |
pmid:7570950
|
Chan K et al. |
Kidney transplantation with minimized maintenance: alemtuzumab induction with tacrolimus monotherapy--an open label, randomized trial. |
2011 |
Transplantation |
pmid:21836540
|
Jain AB et al. |
A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil in primary adult liver transplant recipients: an interim report. |
1998 |
Transplantation |
pmid:9846530
|
Qi S et al. |
Effect of tacrolimus (FK506) and sirolimus (rapamycin) mono- and combination therapy in prolongation of renal allograft survival in the monkey. |
2000 |
Transplantation |
pmid:10798741
|
Borger P et al. |
Cyclosporine, FK506, mycophenolate mofetil, and prednisolone differentially modulate cytokine gene expression in human airway-derived epithelial cells. |
2000 |
Transplantation |
pmid:10798763
|
Kovarik JM et al. |
Pharmacokinetics of sotrastaurin combined with tacrolimus or mycophenolic acid in de novo kidney transplant recipients. |
2011 |
Transplantation |
pmid:21157403
|
Jugie M et al. |
Study of the impact of liver transplantation on the outcome of intestinal grafts in children. |
2006 |
Transplantation |
pmid:16612274
|
Vyas S et al. |
Outcome of twin pregnancy in a renal transplant recipient treated with tacrolimus. |
1999 |
Transplantation |
pmid:10030303
|
Song L et al. |
Effects of ASKP1240 combined with tacrolimus or mycophenolate mofetil on renal allograft survival in Cynomolgus monkeys. |
2014 |
Transplantation |
pmid:24992357
|
Shivaswamy V et al. |
Metformin improves immunosuppressant induced hyperglycemia and exocrine apoptosis in rats. |
2013 |
Transplantation |
pmid:23250335
|
Xu H et al. |
Simultaneous bone marrow and composite tissue transplantation in rats treated with nonmyeloablative conditioning promotes tolerance. |
2013 |
Transplantation |
pmid:23250336
|
Hudnall SD |
Cardiac hypertrophy postliver transplantation: a role for FK506 and cyclosporine A? |
2002 |
Transplantation |
pmid:12369583
|
Molmenti EP et al. |
Kidney transplantation for end-stage renal failure in liver transplant recipients with hepatitis C viral infection. |
2001 |
Transplantation |
pmid:11213072
|
Mourer JS et al. |
Impact of late calcineurin inhibitor withdrawal on ambulatory blood pressure and carotid intima media thickness in renal transplant recipients. |
2013 |
Transplantation |
pmid:23715049
|
Cohen JB et al. |
Belatacept Compared With Tacrolimus for Kidney Transplantation: A Propensity Score Matched Cohort Study. |
2017 |
Transplantation |
pmid:27941427
|
Bolley R et al. |
Tacrolimus-induced nephrotoxicity unmasked by induction of the CYP3A4 system with St John's wort. |
2002 |
Transplantation |
pmid:11923712
|
Yoshimura N et al. |
A case report of pregnancy in renal transplant recipient treated with FK506 (tacrolimus). |
1996 |
Transplantation |
pmid:8633388
|
Puig I Marà JM et al. |
Reflex sympathetic dystrophy syndrome of the lower limbs in a renal transplant patient treated with tacrolimus. |
2000 |
Transplantation |
pmid:10919604
|
Erickson LM et al. |
Microarray-based gene expression profiles of allograft rejection and immunosuppression in the rat heart transplantation model. |
2003 |
Transplantation |
pmid:12923448
|
Maluccio M et al. |
Tacrolimus enhances transforming growth factor-beta1 expression and promotes tumor progression. |
2003 |
Transplantation |
pmid:12923450
|
Furian L et al. |
Everolimus associated with low-dose calcineurin inhibitors, an option in kidney transplant recipients of very old donors. |
2014 |
Transplant. Proc. |
pmid:25498057
|
Kinoshita I et al. |
Immunosuppression with FK 506 insures good success of myoblast transplantation in MDX mice. |
1994 |
Transplant. Proc. |
pmid:7527978
|
Porayko MK et al. |
Nephrotoxicity of FK 506 and cyclosporine when used as primary immunosuppression in liver transplant recipients. |
1993 |
Transplant. Proc. |
pmid:7679835
|
Iwasaki K et al. |
Pharmacokinetic study of FK 506 in the rat. |
1991 |
Transplant. Proc. |
pmid:1721268
|
Andersson J et al. |
FK 506 and cyclosporine inhibit antigen- or mitogen-induced monokine and lymphokine production in vitro. |
1992 |
Transplant. Proc. |
pmid:1371621
|
Takada S et al. |
HGF prevents tacrolimus (FK 506)-induced nephrotoxicity in SHR rats. |
1996 |
Transplant. Proc. |
pmid:8623236
|
Van Buren D et al. |
Renal function in primary liver transplant recipients receiving neoral (cyclosporine) versus prograf (tacrolimus). |
1998 |
Transplant. Proc. |
pmid:9636566
|
Ichikura H et al. |
Conversion of renal transplant immunosuppression from tacrolimus (FK 506) to cyclosporine: a single center experience. |
2000 |
Transplant. Proc. |
pmid:11119911
|
Francavilla A et al. |
FK 506 as a growth control factor. |
1990 |
Transplant. Proc. |
pmid:1689912
|
Barreto P et al. |
Conversion From Twice-Daily to Once-Daily Tacrolimus in Stable Kidney Graft Recipients. |
2016 |
Transplant. Proc. |
pmid:27742278
|
Alloway RR et al. |
Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience. |
1996 |
Transplant. Proc. |
pmid:8623494
|
Dumont FJ et al. |
Up-regulation of gene expression by FK 506. |
1991 |
Transplant. Proc. |
pmid:1721300
|
Bruce DS et al. |
Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation. |
1998 |
Transplant. Proc. |
pmid:9636625
|
Moffatt SD and Metcalfe SM |
FK 506 versus cyclosporine in combination with anti-CD4/CD8 monoclonal antibodies. |
1999 |
Transplant. Proc. |
pmid:10578271
|
Amada N et al. |
Deoxyspergualin prophylaxis with tacrolimus further improves long-term graft survival in living-related renal-transplant recipients transfused with donor-specific blood. |
2005 |
Transplant. Proc. |
pmid:15848577
|
YaÄŸmurdur MC et al. |
Tacrolimus conversion in kidney transplant recipients: analysis of 107 patients. |
2004 Jan-Feb |
Transplant. Proc. |
pmid:15013327
|
Kim SJ et al. |
A 6-month, multicenter, single-arm pilot study to evaluate the efficacy and safety of generic tacrolimus (TacroBell) after primary renal transplantation. |
2009 |
Transplant. Proc. |
pmid:19545705
|
Sánchez-Lázaro IJ et al. |
Preliminary results of a prospective randomized study of cyclosporine versus tacrolimus in the development of cardiac allograft vasculopathy at 1 year after heart transplantation. |
2010 |
Transplant. Proc. |
pmid:20970650
|
Tanabe K et al. |
Synergistic effect of high-dose mizoribine and low-dose tacrolimus on renal allograft survival in nonhuman primates. |
2002 |
Transplant. Proc. |
pmid:12176425
|
Takara T et al. |
Intraportal donor-specific transfusion given 24 hours before small bowel transplantation with cyclosporine and FK 506. |
1994 |
Transplant. Proc. |
pmid:7518150
|
Jain A et al. |
Intravenous, oral pharmacokinetics, and oral dosing of FK 506 in small bowel transplant patients. |
1992 |
Transplant. Proc. |
pmid:1376518
|
Watanabe K et al. |
Factors influencing long-term operational tolerance in dogs treated with fractionated lymphoid irradiation, donor bone marrow cell infusion and FK506. |
1995 |
Transplant. Proc. |
pmid:7533389
|
Borg AJ and Kumagai M |
FK 506 and xenogeneic human anti-porcine cellular reactivity. |
1991 |
Transplant. Proc. |
pmid:1721332
|
Sugitani A et al. |
Long-term results of tacrolimus therapy for renal transplantation in patients with diabetic nephropathy in Japan. |
2005 |
Transplant. Proc. |
pmid:15919459
|
Lemster B et al. |
Cytokine gene expression in murine lymphocytes activated in the presence of FK 506, bredinin, mycophenolic acid, or brequinar sodium. |
1992 |
Transplant. Proc. |
pmid:1281576
|
Yoshimura N et al. |
Effect of local immunosuppressive therapy with FK 506 on renal allograft survival in the mongrel dog. |
1998 |
Transplant. Proc. |
pmid:9838372
|
Jensen CW et al. |
Pediatric renal transplantation under FK 506 immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1721364
|
Bartlomiejczyk I et al. |
Therapeutic monitoring of tacrolimus concentrations in blood of renal and liver transplant recipients: comparison of microparticle enzyme immunoassay and enzyme multiplied immunoassay methods. |
2006 Jan-Feb |
Transplant. Proc. |
pmid:16504673
|
McCauley J et al. |
The question of FK 506 nephrotoxicity after liver transplantation. |
1991 |
Transplant. Proc. |
pmid:1703344
|
Hernández D et al. |
Cardiovascular risk profile in nondiabetic renal transplant patients: cyclosporine versus tacrolimus. |
2003 |
Transplant. Proc. |
pmid:12962773
|
Bonatti H et al. |
Liver transplantation for acute liver failure in children under 1 year of age. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123068
|
Cicalese L et al. |
Effect of FK506 on the mucosal perfusion of the rat intestinal allograft. |
1996 |
Transplant. Proc. |
pmid:8907959
|
Craig AM et al. |
A cost-effectiveness analysis of tacrolimus versus cyclosporine microemulsion following kidney transplantation. |
2002 |
Transplant. Proc. |
pmid:12176519
|
Youbin Z et al. |
Tumor Necrosis Factor-α-Induced Protein 8-Like 2 Gene Overexpression Prolongs the Survival of Rat Allogeneic Heart Allografts. |
2015 |
Transplant. Proc. |
pmid:26518962
|
Yamamoto T et al. |
Efficacy of Eculizumab Therapy for Atypical Hemolytic Uremic Syndrome Recurrence and Antibody-Mediated Rejection Progress After Renal Transplantation With Preformed Donor-Specific Antibodies: Case Report. |
|
Transplant. Proc. |
pmid:28104125
|
Navia MA |
Rational design of new immunosuppressive drugs. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083489
|
Sato K et al. |
Pancreaticoduodenal allotransplantation with cyclosporine and FK506. |
1989 |
Transplant. Proc. |
pmid:2468212
|
Tsao CI et al. |
Unplanned readmission within 1 year after heart transplantation in Taiwan. |
2010 |
Transplant. Proc. |
pmid:20430212
|
Gruessner AC et al. |
Solitary pancreas transplants: improving results and factors that influence outcome. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123468
|
Jonas S et al. |
Corticosteroid-free therapy after tacrolimus-based dual immunosuppression versus cyclosporine-based quadruple-induction therapy. |
2001 |
Transplant. Proc. |
pmid:11377511
|
Boucher A et al. |
Impact of immunosuppressive regimen on cardiovascular risk factors in kidney transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176582
|
Chang HR et al. |
Predictors of renal function improvement following tacrolimus conversion in cyclosporine-treated kidney transplant recipients. |
2007 |
Transplant. Proc. |
pmid:18089339
|
Lee KH et al. |
Distribution of Anti-ABO Immunoglobulin G Subclass and C1q Antibody in ABO-incompatible Kidney Transplantation. |
2018 |
Transplant. Proc. |
pmid:29731066
|
Wang W et al. |
Effect of rapamycin and FK506 on mesangial cell proliferation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267180
|
Fukuzawa M et al. |
Effect of donor-specific transfusion and FK 506 on small intestine allotransplantation. |
1991 |
Transplant. Proc. |
pmid:1721427
|
Park KM et al. |
Bone loss after orthotopic liver transplantation: FK 506 versus cyclosporine. |
1996 |
Transplant. Proc. |
pmid:8658863
|
Venkataramanan R et al. |
Biopharmaceutical aspects of FK-506. |
1987 |
Transplant. Proc. |
pmid:2445070
|
Curtis JJ |
Posttransplant hypertension. |
1998 |
Transplant. Proc. |
pmid:9723370
|
Li Y et al. |
Long-term comparison of rat model of chronic allograft rejection of orthotopic small bowel transplantation induced by cyclosporine versus tacrolimus. |
2013 |
Transplant. Proc. |
pmid:23769050
|
Kanodia KV et al. |
Study of acute antibody-mediated rejection in renal allograft biopsies. |
2008 |
Transplant. Proc. |
pmid:18555123
|
Fung JJ and Starzl TE |
FK 506 in solid organ transplantation. |
1994 |
Transplant. Proc. |
pmid:7524226
|
Langrehr JM et al. |
A prospective, randomized trial with quadruple versus dual tacrolimus-based induction after liver transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267404
|
McCauley J et al. |
FK 506 in the management of transplant-related nephrotic syndrome and steroid-resistant nephrotic syndrome. |
1991 |
Transplant. Proc. |
pmid:1721459
|
Toki K et al. |
Histopathologic findings in routine biopsies of renal transplant allografts. |
1999 |
Transplant. Proc. |
pmid:10500759
|
Griffin AD et al. |
FK 506 in canine renal transplantation. |
1992 |
Transplant. Proc. |
pmid:1384209
|
Silber RE et al. |
Comparison of the effect of FK 506 and alpha/beta-T-cell antibody R73 on transplant vascular sclerosis after heterotopic rat heart transplantation. |
1998 |
Transplant. Proc. |
pmid:9636398
|
Barten MJ et al. |
Assessment of immunosuppression by lymphocyte functions in human blood. |
2002 |
Transplant. Proc. |
pmid:12431640
|
Kacar S et al. |
Low-dose calcineurin inhibitor regimen combined with mammalian target of rapamycin inhibitors preserves kidney functions in renal transplant recipients without allograft nephropathy. |
2010 |
Transplant. Proc. |
pmid:21094806
|
Bing P et al. |
Comparison of expression of TGF-beta1, its receptors TGFbeta1R-I and TGFbeta1R-II in rat kidneys during chronic nephropathy induced by cyclosporine and tacrolimus. |
2006 |
Transplant. Proc. |
pmid:16980036
|